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Abstract: Pleomorphic adenoma (PA) is the most common neoplasm encoun-
tered  in major and minor salivary glands. Intraorally, it is most frequently
developed in the palatal glands. Histologically, it is characterized by a diverse
architecture comprised of  epithelial stromal elements mixed with mucoid,
myxoid, or chondroid fibrohyaline. A PA does not generally present gender
bias and can occur at any age with the same clinical behavior. It is usually a
round, slow-growing, painless tumor, which is firm upon palpation. We reported
two cases of  adult patients who were treated using transoral resection at San
Juan de Dios Hospital in La Serena.
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Adenoma pleomorfo palatino: Reporte de 2 casos y revisión
de la literatura.
Abstract: El Adenoma Pleomorfo es la neoplasia más común de las glándulas
salivales mayores y menores. Intraoralmente las glándulas del paladar son las
más afectadas. Histológicamente se caracteriza por una arquitectura variada
que comprende elementos epiteliales mezclados con estroma mucoide, mixoide,
fibrohialino o condroide,  Los AP no suelen presentar predisposición por sexos,
pudiendo aparecer a cualquier edad, con el mismo comportamiento clínico. Se
presentan habitualmente como una tumoración redondeada de crecimiento
lento, indolora y firme a la palpación. Presentamos dos casos de pacientes
adultos, quienes fueron tratados mediante resección transoral en el hospital de
la Serena.
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Introduction.
Pleomorphic Adenoma (PA) is the most common
of  benign salivary gland tumors (80%)1. It is an
epithelial derivation and normally appears as a well-
circumscribed, benign tumor, which may or may not
be encapsulated2.
Approximately, 75% of  PAs occur in the parotid
gland. Other common sites are the submandibular
gland (15%) and minor salivary glands of  the palate
and nasal septum (10%). They appear less frequently
in the minor salivary glands of  the upper lip, cheeks,
floor of  the mouth, larynx and trachea3.  The most
frequent location of  the pleomorphic adenoma in the
minor salivary glands is the hard palate, followed by
lips, oral mucus, floor of  the mouth, tonsil, pharynx,
retromolar area and nasal cavity4.
Histologically, it is characterized by a diverse
architecture comprised of  epithelial stromal elements
mixed with mucoid, myxoid, or chondroid fibrohyaline4
located in the depths of  the submucus.  Tumors in
the salivary glands lack fibrotic encapsulation, giving
a false appearance of  infiltration (although, they
possess a very thin capsule)5.
Historically, the main clinical problems have been
risk of  recurrence and possible malignant
transformation6. However, mixed malignant tumors,
which include carcinoma, ex-pleomorphic adenoma
(malignant transformation of  benign pleomorphic
adenoma), carcino-sarcoma or metastasizing pleomor-
phic adenoma (MPA), are rare and represent 2 to 6%
of  salivary gland tumors6.
Clinical signs of  malignancy in pleomorphic ade-
noma are the following:
1. Brusque acceleration of  growth in a tumor that
has been present for 10 to 30 years.
2. Irregular surface of  the tumor and adherence to
skin.
3. Appearance of  superficial vascular alterations, at
times with telangiectases or necrosis, which can be
observed to fluctuate in the necrotic areas and attach-
ment to other tissues. Ulceration may be present.
4. Sensation of  tightness or pressure changes to
pain7.
PAs do not normally present gender predisposition,
appearing at any age and with the same clinical behavior.
They are usually a round, slow-growing, painless tumor,
which is firm upon palpation8.
Tumor-like lesions in the palate are not infrequent
in clinical practice and their possible diagnoses, con-
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sidering the posterior location of  the hard palate, could
include9:
1. Dental or periodontal infection.
2. Benign or malignant neoplasia of  salivary glands.
3. Soft tissue tumor, including a wide variety of
tissues (fibrous tissue, fat, muscle, nerves and vessels).
This group involves a large variety of  lesions
from fibromas to alveolar sarcoma of  soft parts.
The most frequent masses found in the palate are
mixed tumors (pleomorphic adenoma) of  the salivary
gland followed by mucoepidermoid carcinoma10-11.
Diagnosis of  PA depends on clinical findings, tissue
sampling and radiographic images by means of  CT
with contrast and MRI in T1 and T29.  These tests are
essential to evaluate with utmost precision the extension
and anatomical relations of  the tumor to be able to
plan an effective surgical treatment4.
Due to its initial benign behavior, it is best to use
the most conservative surgical techniques whenever
excision is possible. Prognosis is excellent if  the
resection has been effectively performed. Another
therapeutic option is post-operatory radiotherapy
which reduces the recurrence rate; above all, when
the capsule has broken during surgery and for patients
whose border of  normal tissue surrounding the
resected tumor was very narrow12. In those cases,
periodical check-ups are necessary due to the possibility
of  local recurrence and malignancy12.
The objective of  this publication is to describe two
clinical cases of  Pleomorphic Adenoma, treated in the
Unit of  Surgery of  San Juan de Dios Hospital in La
Serena, and carry out a literature review about this
pathology.
Case 1.
One of  the patients was a sixty-five year-old female.
She had a history of  hypertension and diabetes and
was allergic to acetylsalicylic acid. In May 2010, she
consulted the Head & Neck and Maxillofacial Team
at San Juan de Dios Hospital in La Serena due to an
increase in palate volume over a period of  two years.
In the transoral exam, a 3x4 cms tumor could be
observed in the left palatal area (Fig. 1). It was covered
with normal mucus, well-circumscribed, firm and
painless upon palpation. There was no sensory or
motor deficiency and no clinical evidence of  alterations
in the general physical exam.
Imaging (computerized tomography) showed a
hypodense lesion in the left posterior hard palate. It
was well-defined and slightly lobulated, measuring
20.25x21.19x13 mm in its maximum diameter. An
imprint of  the lesion could also be observed in the
maxillary and palatal bones (Fig. 2).
Before definitive surgery, an incisional biopsy of
the involved area was carried out; the histopathological
report of  tissue samples confirmed a Pleomorphic
Adenoma (Fig. 3).
Considering the clinical study, imaging and histology,
a mucoperiostic resection of  the lesion, with a safety
margin of  one centimeter13, was planned for January
2011, thus confirming the initial pathology. The inter-
vened area was left with a prosthesis (attached with
screws and wires due to the absence of  maxillary teeth)
and iodized gauze for approximately 18 days (Fig. 4).
In November 2011, hyperplastic tissue was clinically
observed in the area of  the original lesion; it was
removed and biopsied, the report informing conjunctive
epithelial  hyperplasia with mild dysplasia.
At present, three years after the resection, there has
been no sign of  recurrence, observing a palate with
normal cicatrization (Fig. 5).
Case 2.
The other patient was a thirty-six year-old female,
with no history of  systemic illnesses and allergic to
penicillin. In 2004, she consulted The Head & Neck
and Maxillofacial Team at San Juan de Dios Hospital
47
Venegas O, Jaramillo L, Nicola M, Covarrubias N, Martínez B & Olivos B. Pleomorphic adenoma of  the palate: Two cases
report and literature review. J Oral Res 2014; 3(1): 46-49.
Figure 1. Left palatine tumor well located, 3x4 cm. Figure
2. Brain CT, lesion on left hard palate, 20,25mm x 21,19mm
x 13,00mm, imprinting over maxillar and palatine bones.
Figure 3.  Epithel ia l  cel l
proliferation over a hyaline
stroma. Oval cells, some with
elongated nuclei and formation
of  ductal  structures are
observed. 500X magnification.
Figure 4. Postsurgical area with
prostheses fixed with screws and
wires. Figure 5. 3 years follow-
up, no recurrence and normal
scar were observed.1
2 3
4 5
in La Serena due to an increase in palate volume over
a period of  seven months.
In the transoral exam, a 2x2 cms tumor could be
observed in the left palatal area. It was covered with
normal mucus, well-circumscribed, firm and painless
upon palpation (Fig.6). There was neither sensory or
motor deficiency nor alterations in the general physical
exam.
Imaging (computerized tomography) showed a
hypodense lesion in the left posterior hard palate,
without bone involvement (Fig.7).
Before the final surgical procedure, an incisional
biopsy of  the pathology was performed, confirming
pleomorphic adenoma.
After taking into consideration the results of  all
exams carried out, a mucoperiostic resection was
planned with a safety margin of  one centimeter. (Fig.
8) The intervened area was covered with iodized gauze
and a splint or maxillary prosthesis with retainers for
approximately two weeks.
No recurrence was exhibited in the patient’s posterior
evaluation in January, 2013 and the palate presented
normal characteristics (Fig. 9).
Discussion.
Pleomorphic adenoma, or mixed benign tumor,
represents 80% of  all benign tumors of  salivary glands,
its main location being the parotid. However, it can be
found in minor salivary glands and in this case, the
palate is the most frequent location1-4, as seen in the
two cases described above.
As indicated by literature and in agreement with
the cases presented, its clinical appearance can occur
at any age8. It is slow-growing and, generally, asymp-
tomatic, supporting the benign component of  these
tumors. The reason for seeking medical consultation
is volume increase, which, upon examination, shows
a firm mass, covered with normal mucus, without
swallowing or voice alterations. Generally, tumors of
the salivary glands are discovered during routine clinical
exams as an asymptomatic mass14; however, patients
in both clinical cases presented sought medical consul-
tation spontaneously.
For the histological study, an incisional biopsy was
performed, demonstrating PA in both cases, thus
confirming the assumed initial diagnosis.  The treatment
which followed was a complete mucoperiostic surgical
resection, with a safety margin of  one centimeter of
healthy mucus, using transoral access. Some authors
describe the superficial scraping or curettage of  adjacent
bone tissue; this is due to the possible presence of
remainders of  PA on the bone surface and not to the
infiltration of  the bone15. Pedemonte et al. indicates
that, in the oral cavity, mucoperiostic surgical extirpation
of  the lesions located in the palate must be performed.
With a correct surgical technique, the recurrence of
PA is less than 5%. Risk of  recurrence seems to be
less in minor salivary glands14. It is important to point
out that, in the palate, tumor cells are usually found in
the capsule. Besides, when the capsule is incomplete,
it is believed that these nests of  neoplastic cells that
perforated the capsule may form new tumor sites. If
simple tumor enucleation is carried out, these cells may
not be completely eliminated leading to possible recur-
rence. Therefore, resection of  the pleomorphic ade-
noma must be mucoperiostic with a safety margin13
and it must be done after an incisional biopsy that
confirms the correct histopathological diagnosis14. This
was done in both of  the clinical cases presented.
Recurrence of  PA is mainly determined by the
rupture of  the tumor during surgery or incomplete
resection16. At present, both patients attend follow-up
consults and neither Case N° 1 nor Case N° 2 has
suffered recurrence after three and nine years, respec-
tively. However, recurrence incidence is minimized or
disappears in all locations when the tumor is removed
with a safety margin of  normal tissue, as in both clinical
cases presented.
In conclusion, it is necessary to recognize these
firm and painless tumors in the palate and, considering
the risk of  malignancy, it is essential the opportune
referral and treatment in benefit of  our patients.
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Figure 6. Left palatine tumor, 2x2cm. Figure 7. CT shows the
palatine lesion on the left posterior area, without bone
compromise. Figure 8. Resection of  the lesion. Figure 9. 9
yea r s  fo l low-up,  no  r ecur rences  were  obse r ved .
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